![Peter Wijngaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Peter L.
J.
Wijngaard is the founder of Corsera Health, Inc. Former jobs include Chairman at Aurinia Pharmaceuticals, Inc. from 2011 to 2013, Independent Director at Hepion Pharmaceuticals, Inc. from 2020 to 2023, Director at Ciclofilin Pharmaceuticals, Inc. from 2014 to 2016, Director-Global Alliance at Hoffmann-La Roche, Inc., Independent Non-Executive Director at Isotechnika Pharma, Inc. from 2011 to 2013, and VP-Innovation Leader Research & Development at The Medicines Company (Schweiz) GmbH.
Education includes a doctorate from the University of Utrecht conferred in 1992.
Eerdere bekende functies van Peter Wijngaard
| Bedrijven | Functie | Einde |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 04-12-2023 |
The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | 01-01-2020 |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Directeur/Bestuurslid | 01-06-2016 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Directeur/Bestuurslid | 23-10-2013 |
Opleiding van Peter Wijngaard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
38
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
The Medicines Company (Schweiz) GmbH | |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
